Basic Science Catalyzing Treatments for Glaucoma

青光眼的基础科学催化治疗

• 批准号: 9391815
• 负责人: W Daniel Stamer
• 金额: $ 2.41万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-01 至 2018-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9391815
• 关键词: Academia; Area; Award; Back; Basic Science; Blindness; Cellular biology; Clinical; Clinical Research; Collaborations; Development; Diagnosis; Disease; Disease Progression; Doctor of Medicine; Doctor of Philosophy; Environment; Ethnic group; Eye; Feedback; Fellowship; Foundations; Functional disorder; Funding; Future; Gene Mutation; Glaucoma; Goals; Homeostasis; Individual; Industry; Institution; International; Knowledge; Learning; Location; Mind; Molecular; Monitor; Morehouse School of Medicine; Natural regeneration; Ophthalmologist; Optic Disk; Participant; Pathogenesis; Pathology; Patient Care; Patients; Physiologic Intraocular Pressure; Public Health; Recording of previous events; Recruitment Activity; Research; Research Personnel; Resources; Retinal Ganglion Cells; Scientist; Secure; Senior Scientist; Societies; Structure; Students; Therapeutic; Tissues; Translating; Translational Research; Translations; Travel; Underrepresented Minority; Universities; Vision; Woman; Work; career; career development; cell injury; educational atmosphere; ethnic diversity; imaging modality; interest; lectures; meetings; neuroprotection; new technology; novel; posters; role model; social; student participation; symposium; translational impact

Summary This proposal seeks support for the 2017 International Society for Eye Research (ISER)-BrightFocus Foundation (BFF) glaucoma meeting titled "Basic Science Catalyzing Treatments for Glaucoma" to be held October 5th – 7th, 2017 in Atlanta, Georgia at the Emory Conference Center Hotel. As with the inaugural meeting that was held in Sarasota, FL in 2013, the goal of this meeting is to bring together basic scientists, clinician-scientists, students and fellows for presentations and in-depth discussions on the molecular mechanisms that underlie glaucomatous pathology, both at the level of the conventional outflow tract and optic nerve head. Additionally, novel technologies developed (i) to diagnose and monitor disease progression, (ii) modify/restore glaucomatous dysfunction and (ii) regenerate damaged cells/tissues will be presented. We have already recruited 6 thought leaders in glaucoma to give keynote lectures at the conference. As with the first meeting, the eleven platform sessions will be selected exclusively from submitted abstracts. We have reserved one of the platform sessions and we are putting on a one-day "crash course" in glaucoma exclusively for junior investigators, consistent with our goal of increasing student and junior investigator participation. ISER and BFF have an established history for promoting diversity, and the speakers that are selected from abstracts will represent a diverse group of scientists that includes women and underrepresented individuals. The Specific Aims of the conference are: 1. To enhance the emerging careers of 22 young scientists (including women and underrepresented minorities) in glaucoma and increase student participation in the meeting by providing travel awards. 2. To provide a forum for dissemination of the most recent advances in the state of knowledge on glaucoma. 3. To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. 4. To bring together scientists working in disparate areas of glaucoma research. We anticipate that this meeting will provide useful information on recent advances in glaucoma and will serve as an important resource for those involved in the translation of these findings into suitable therapeutics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 12 students (pre- and postdoctoral) and 10 junior investigators who otherwise would not have the resources to attend this focused meeting.

概括 该提案寻求2017年国际眼科研究学会（ISER）的支持-BrightFocus 基金会（BFF）青光眼会议即将举行，题为“青光眼的基础科学催化治疗” 2017 年 10 月 5 日至 7 日在佐治亚州亚特兰大埃默里会议中心酒店举行。和首届一样 2013 年在佛罗里达州萨拉索塔举行的会议，这次会议的目标是将基础科学家聚集在一起， 临床医生、科学家、学生和研究员就分子生物学进行演讲和深入讨论 青光眼病理学的机制，无论是在常规流出道水平还是在 视神经乳头。此外，还开发了 (i) 诊断和监测疾病的新技术 进展，（ii）改变/恢复青光眼功能障碍和（ii）再生受损的细胞/组织将 提出。我们已经招募了 6 位青光眼领域的思想领袖在大会上做主题演讲 会议。与第一次会议一样，十一次平台会议将专门从 提交的摘要。我们已经预订了其中一场平台会议，并且正在举办为期一天的“崩溃”活动 专门针对初级研究人员的青光眼课程”，这符合我们增加学生和 初级研究者的参与。 ISER 和 BFF 在促进多样性方面有着悠久的历史，并且 从摘要中选出的演讲者将代表包括女性在内的多元化科学家群体 和代表性不足的个人。 会议的具体目标是： 1. 促进 22 名年轻科学家（包括女性和代表性不足的科学家）的新兴职业生涯 少数族裔）的青光眼问题，并通过提供旅行奖励来提高学生对会议的参与度。 2. 提供一个论坛，传播有关知识状况的最新进展 青光眼。 3. 创造一个有利于基础和临床医生之间交流新思想的环境 科学家，并为所有种族和社会的视觉科学家创造机会 背景以满足并建立研究合作。 4. 将青光眼研究不同领域的科学家聚集在一起。 我们预计本次会议将提供有关青光眼最新进展的有用信息，并将为 对于那些参与将这些发现转化为合适的治疗方法的人来说，这是一个重要的资源。 此次会议还将提供新机遇、新发现的途径以及发展的论坛 与会者之间的潜在合作。所申请的资金将用于支持旅行、住宿 12 名学生（博士前和博士后）和 10 名初级研究人员的注册，否则他们不会 有资源参加这次重点会议。